-
UPDATE: Wedbush Downgrades AngioDynamics to Underperform
Tuesday, June 14, 2011 - 9:10am | 129Read More...Wedbush is out with its report today on AngioDynamics (NASDAQ: ANGO), downgrading ANGO to Underperform. In a note to clients, Wedbush writes, "It is a very tough operating environment, and the outlook for ANGO's performance has recently gotten a lot cloudier. With a management transition now...
-
Gabelli Downgrades AngioDynamics To Sell
Tuesday, June 14, 2011 - 8:54am | 18Read More...Gabelli has downgraded AngioDynamics (NASDAQ: ANGO) from Hold to Sell.
-
Wedbush Downgrades AngioDynamics To Underperform, Lowers PT To $12
Tuesday, June 14, 2011 - 7:56am | 27Read More...Wedbush Securities has downgraded AngioDynamics (NASDAQ: ANGO) from Neutral to Underperform and has lowered the price target from $14 to $12.
